VRAX (Virax Biolabs Group) Days Payable : 332.68 (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Virax Biolabs Group Days Payable?

Virax Biolabs Group's average Accounts Payable for the six months ended in Mar. 2025 was $0.09 Mil. Virax Biolabs Group's Cost of Goods Sold for the six months ended in Mar. 2025 was $0.05 Mil. Hence, Virax Biolabs Group's Days Payable for the six months ended in Mar. 2025 was 332.68.

The historical rank and industry rank for Virax Biolabs Group's Days Payable or its related term are showing as below:

VRAX' s Days Payable Range Over the Past 10 Years
Min: 315.51 Med: 590.04 Max: 18359.5
Current: 455.73

During the past 6 years, Virax Biolabs Group's highest Days Payable was 18359.50. The lowest was 315.51. And the median was 590.04.

VRAX's Days Payable is ranked better than
77.27% of 704 companies
in the Biotechnology industry
Industry Median: 118.35 vs VRAX: 455.73

Virax Biolabs Group's Days Payable declined from Mar. 2024 (1,037.97) to Mar. 2025 (332.68). It may suggest that Virax Biolabs Group accelerated paying its suppliers.

Virax Biolabs Group Days Payable Historical Data

The historical data trend for Virax Biolabs Group's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virax Biolabs Group Days Payable Chart

Virax Biolabs Group Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Days Payable

Get a 7-Day Free Trial

590.04

18,359.50

358.05

315.51

Virax Biolabs Group Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
Days Payable	Get a 7-Day Free Trial						13,390.94	786.69	1,037.97	1,368.75	332.68

Competitive Comparison of Virax Biolabs Group's Days Payable

For the Biotechnology subindustry, Virax Biolabs Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Virax Biolabs Group's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Virax Biolabs Group's Days Payable distribution charts can be found below:

* The bar in red indicates where Virax Biolabs Group's Days Payable falls into.

Save Embed

;

Save Embed

;

Virax Biolabs Group Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Virax Biolabs Group's Days Payable for the fiscal year that ended in Mar. 2025 is calculated as

	Days Payable (A: Mar. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2024 )	+	Accounts Payable (A: Mar. 2025 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2025 )	*	Days in Period
=	( (0.046	+	0.056)	/	2 )	/	0.059	*	365
=	0.051					/	0.059	*	365
=	315.51

Virax Biolabs Group's Days Payable for the quarter that ended in Mar. 2025 is calculated as:

	Days Payable (Q: Mar. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Mar. 2025 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2025 )	*	Days in Period
=	( (0.119	+	0.056)	/	2 )	/	0.048	*	365 / 2
=	0.0875					/	0.048	*	365 / 2
=	332.68

Virax Biolabs Group Days Payable Related Terms

Thank you for viewing the detailed overview of Virax Biolabs Group's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Virax Biolabs Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bo’Ness Road Newhouse, BioCity Glasgow, London, GBR, ML1 5UH

Website

https://www.viraxbiolabs.com

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.